Table 2.
Association of CD4 count and VL subgroups by GBTM of 7,485 PLHIV during ART follow-ups in Dehong, Southwest China, 2008–2021
| Follow-up VL | Follow-up CD4 count No. (%), cells/µl | Total | ||
|---|---|---|---|---|
| < 350 | 350 ~ 499 | ≥ 500 | ||
| VL suppression | 1,846 (28.7) | 2,626 (40.8) | 1,959 (30.5) | 6,431 (85.9) |
| LLV | 327 (44.8) | 265 (36.3) | 138 (18.9) | 730 (9.8) |
| NSV | 187 (57.7) | 109 (33.6) | 28 (8.6) | 324 (4.3) |
| Total | 2,360 (31.5) | 3,000 (40.1) | 2,125 (28.4) | 7,485 (100.0) |
Abbreviation: ART, antiretroviral therapy; CD4, CD4 + T lymphocytes; GBTM, group-based trajectory models; HIV, human immunodeficiency virus; LLV, low-level viremia; NSV, non-suppressed viremia; PLHIV, persons living with HIV; VL, viral load